Generic drugmaker Mylan NV has offered concessions to address European Union antitrust concerns about its bid for Pfizer’s off-patent branded drugs business Upjohn, a filing on the European Commission site showed on Monday. U.S. drugmaker Pfizer announced the deal in July as part of a strategy allowing it to focus on its more profitable newer medicines. The European Commission set an April 22 deadline for its decision after Mylan put in its offer on March 27. …read more
Source:: Yahoo Finance
